Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Sep 5.
Published in final edited form as: J Obsessive Compuls Relat Disord. 2014 Mar 26;3(4):372–379. doi: 10.1016/j.jocrd.2014.03.004

Clinical Features of Tourette Syndrome and Tic Disorders

James F Leckman 1, Robert A King 2, Michael H Bloch 3
PMCID: PMC6124690  NIHMSID: NIHMS985224  PMID: 30197854

Abstract

Background:

Tourette syndrome (TS) is a neurodevelopmental disorder characterized by motor and vocal tics--rapid, repetitive, stereotyped movements or vocalizations lasting at least one year in duration. The goal of this article was to review the long-term clinical course of tics and frequently co-occurring conditions in children with TS.

Methods:

We conducted a traditional literature search to locate relevant articles regarding long-term outcome and prognosis in TS and tic disorders.

Results:

Tics typically have an onset between the ages of 4 and 6 years and reach their worst-ever severity between the ages of 10 and 12 years. By age 10 years, most children are aware of nearly irresistible somatosensory urges that precede the tics. A momentary sense of relief typically follows the completion of a tic. Over the course of hours, tics occur in bouts, with a regular inter-tic interval. Tics increase during periods of psychosocial stress, emotional excitement and fatigue. Tics can become “complex” in nature and appear to be purposeful. Tics can be willfully suppressed for brief intervals and can be evoked by the mere mention of them. Tics typically diminish during periods of goal-directed behavior. Over the course of months, tics wax and wane. By early adulthood, roughly three-quarters of children with TS will have greatly diminished tic symptoms and more than one-third will be virtually tic free.

Conclusion:

Although tics are the defining aspect of TS, they are often not the most enduring or impairing symptoms in children with TS. Indeed in TS tics rarely occur in isolation, and other coexisting conditions--such as behavioral disinhibition, hypersensitivity to a broad range of sensory stimuli, problems with visual motor integration, procedural learning difficulties, attention-deficit hyperactivity disorder, obsessive-compulsive disorder, depression, anxiety, and emotional instability--are often a greater source of impairment than the tics themselves. Measures used to enhance self-esteem, such as encouraging independence, strong friendships and the exploration of interests, are crucial to ensuring positive adulthood outcome.


I finally apprehend the magnitude of the background noise that I have been experiencing for decades… the people around me do not share my tics because they do not hear the drumbeat. They do not feel the sensations without sources, do not have irresistible urges to pause in midsentence, do not receive strict internal commands to trace with their eyes in midair the shape of each of Aristotle’s regular solids, and so on in endless, bewildering variety… Finally and most important, I feel convinced that this complex challenging enigmatic internal world is the obvious core of Tourette’s [1].

Tic disorders have been the subject of speculation for at least 300 years. In the past 25 years, Tourette syndrome (TS) has come to be recognized as a model developmental disorder occupying the nexus of neurology and psychiatry [2]. TS is a childhood-onset neuropsychiatric disorder characterized by multiple motor and vocal tics that last at least a year in duration [3]. Once thought to be a rare condition, TS is known to affect four to six in every 1000 children [58]. Transienttic disorder, characterized by tics that are present for less than a year in duration, and chronictic disorders, which are characterized by either motor or vocal tics, but not both, have a prevalence of approximately 20% and 5%, respectively, in children [58]. Individuals with TS commonly experience comorbid psychiatric disorders such as attention-deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD) [412]. These comorbid conditions often cause more impairment in individuals with TS than the tics themselves.

The purpose of this article is to review the clinical course of individuals with TS. We begin by focusing on the nature and course of tic symptoms in TS, then focus on the clinical course of common comorbid conditions and finish by discussing the adulthood global functioning and psychosocial outcome of children with TS [13]. The conclusion will summarize, for clinicians, the prognostic information we use to explain the expected clinical course of TS to families seeking evaluation in our clinic.

Tic symptoms

A tic is a sudden, repetitive, non-rhythmic, stereotyped motor movement or vocalization involving discrete muscle groups [10]. Tics can be described based on their anatomical location, number, frequency, and duration [14]. Another useful descriptor is the intensity or “forcefulness” of the tic, as some tics call attention to themselves simply by virtue of their exaggerated, forceful character [14]. Tics can also be described in terms of their “complexity” [14]. Complexity refers to how simple or involved a movement or sound is, ranging from brief, meaningless, abrupt fragments (simple tics) to ones that are longer, more involved, and seemingly more purposive in character (complex tics). Simple tics are sudden, brief (usually less than 1 second in duration), meaningless movements or sounds. Complex tics are sudden, more purposive appearing, stereotyped movements of longer duration that can include “orchestrated” combinations of motor or vocal or motor and vocal tics. The observed range of tics is extraordinary, so that virtually any voluntary motor movement or vocalization can emerge as a tic.

Tics usually have their onset in the first decade of life around the age of 4–6 years with simple motor movements such as eye blinking, nose twitching, or facial grimaces [10]. Motor tics usually progress in a rostrocaudal direction with time [15]. Vocal tics, when they appear, typically first manifest themselves a year or two after the onset of motor tics [15]. Vocal tics begin as simple vocalizations such as throat clearing, sniffing, or fractions of words [15].

Many TS patients experience premonitory urges [16, 17]. A premonitory urge is a sensory phenomenon that occurs immediately prior to a tic, similar to the need to sneeze or scratch an itch [16, 17]. Individuals often describe the need to tic as the buildup of tension, usually in the body location where the tic is about to occur, but in some individuals the tension occurs throughout the body [16, 17]. Depending on the intensity of the urge the individual may consciously decide to tic or not to tic. However, if the urge is very strong, it can be impossible to resist. The actual tic may be felt as relieving this tension or sensation, similar to scratching an itch. After a tic is done, there is often a fleeting and incomplete sense of relief. Awareness of premonitory urges increases with age and is present in as many as 90% of adolescents with TS [16, 17]. Gaining an awareness of these difficult to describe premonitory urges lies at the heart of habit reversal training which has proven to be one of the most efficacious treatments for TS [18, 19].

During the course of a day tic symptoms of TS generally occur in bouts and over weeks to months they wax and wane in severity [9, 20]. Factors such as psychosocial stress, excitement, anxiety, social events and fatigue are known to exacerbate tics in the moment and psychosocial stress has been shown to be predictive of future tic severity [2124]. However, for many individuals, focused concentration, especially involving fine-motor control such as playing a musical instrument, dancing, or playing sports, can lead to a marked reduction of tics [10]. Many TS patients are able to temporarily suppress tics, but often at the expense of concentration and exhaustion [10]. As children get older they typically develop a greater ability to suppress tics [10]. Interestingly, recent studies suggest that environments conducive to tic suppression result in reduced tic frequency without adverse consequences or a rebound in tic frequency or severity [25].

When Georges Gilles de la Tourette originally described the clinical syndrome that now bears his name, tics were hypothesized to be persistent and lifelong; our current knowledge suggests this is generally not the case [13, 15, 26, 27]. Tics typically emerge around the age of 4–6 years, reach their worst ever point early in the second decade of life, and then, on average, improve during adolescence [13, 15, 26]. Fig. 1 demonstrates the clinical course of tic severity in two cohorts of 42 and 46 children, respectively, with TS followed until early adulthood [15, 26].

Figure 1. Course of Tic Severity over the First Two Decades.

Figure 1.

A. Data on the relative severity of tics are presented for 42 individuals with Tourette syndrome (A-D) [9]. The relative tic severity scale goes from 0 (no tics) to 5 (severe tics). Estimates from the patient and a respective parent were obtained independently.

B. Box plot representing age when tic disorder symptoms were at their worst (N=46) [16].

Fig. 2 describes the early adulthood tic outcome of more than 80 children followed from initial evaluation (average age 11 years) to follow-up in young adulthood [15, 26]. Over one-third of children with TS were completely tic free at follow-up, slightly less than half had minimal to mild tics, and less than a quarter had moderate or greater tics at follow-up. These results contrast to their worst ever period when all individuals experienced at least a moderate level of tic severity. Less than 5% of individuals reported experiencing worse tics in early adulthood than during their childhood. Similar results of tic improvement have been reported in a large cohort of children with tics and co-occurring ADHD [28].

Figure 2. Tic Outcomes in Early Adulthood.

Figure 2.

Tic severity in early adulthood (N=82). Adulthood tic severity class is defined by Yale Global Tic Severity Scale [Total Tic Score] (YGTSS): no tics (YGTSS: 0), minimal tics (YGTSS: 1–9), mild tics (YGTSS: 10–19), moderate or greater tics (YGTSS: ≥20). By contrast, all individuals had moderate or greater severity tics in childhood. Less than 5% of individuals reported having worse adulthood tics than in childhood. Adapted from Fig 2. in Bloch & Leckman [7].

Based on the results of a longitudinal follow-up study of 65 individuals with TS and 65 matched community controls without tic or OCD symptoms, higher levels of tic severity in late adolescence are associated with lower levels of global functioning [29]. Tic severity was also associated with higher internalizing, externalizing, and total problems scores on the Child Behavior Checklist [29, 30]. Individuals with more severe tic severity at age 18 years were also more likely to have co-occurring OCD [29].

Demographic and clinical data, the results of neuropsychological testing, and findings from structural neuroimaging studies obtained in childhood have been assessed to determine whether any of these variables are predictive of tic severity as assessed early in adulthood. In general, childhood clinical characteristics are rather poor determinants of future adulthood tic severity, with only current tic severity in early adolescence being weakly associated with tic severity in early adulthood [26]. Worst ever tic severity and the presence of comorbid illnesses in childhood were not associated with tic severity in adulthood [26]. Poor fine-motor skills in childhood, as measured by the Purdue Pegboard test, were associated with increased adulthood tic severity [31]. Smaller caudate volume on childhood MRI scans was also associated with increased adulthood tic severity [32]. Childhood structural neuroimaging and neuropsychological testing data, although not robust enough to be a useful clinical prognosticator of outcome, does suggest that there may be specific neuropathological processes associated with persistent TS into adulthood. Attention has focused on abnormalities within cortico-striatal-thalamo cortical circuits, possibly involving inhibitory interneurons within the basal ganglia [33, 34]. A full review of the neuropathology and pathophysiology of TS is beyond the scope of this article but has been reviewed in depth elsewhere [3538].

The usual improvement of tic symptoms over the course of adolescence has significant implications for the use of behavioral, pharmacological, and neurosurgical treatments in children with TS. For example, although modestly effective pharmacological treatments for TS (i.e., alpha-2 agonists and antipsychotics) are typically used to reduce impairing tic symptoms, there is no evidence that suggests that these pharmacological treatments alter the long-term course of TS. In the absence of ideal anti-tic medications that could eliminate tics and given the significant potential side effects of the pharmacological agents typically prescribed (such as weight gain on the atypical neuroleptics), these agents should only be administered when a child presents with persistent and significantly impairing tics. In contrast, behavioral interventions such as Comprehensive Behavioral Intervention for Tics (CBIT) should be offered to all patients with impairing tics [39]. It is also important to encourage families to keep their child’s development on track. This often involves psychoeducational interventions with the child, their families, peers and school personnel as well as encouraging the child to participate in developmentally appropriate activities (sports activities, school plays, etc) despite the presence of overt tic symptoms [40]. Finally, more invasive interventions for TS such as deep brain stimulation and neurosurgery are strongly discouraged until well into adulthood, even for patients with impairing tics. This recommendation is made because many children’s tics will improve with time regardless of treatment. A full review of the available treatments for TS is beyond the scope of this review but has been described well elsewhere [3941].

Comorbid conditions

Attention-deficit hyperactivity disorder.

In epidemiologic samples, greater than half of individuals with TS experience comorbid ADHD [7]. The rates are much lower among children with chronic motor or vocal tic disorder [7]. The prevalence of ADHD in patients with TS who reach clinical attention may be even higher [11, 29]. Based on the results of a longitudinal follow-up study of 65 individuals with TS and 65 matched community controls without tic or OCD symptoms, higher levels of ADHD severity in late adolescence are associated with a significantly lower level of global functioning [29]. ADHD severity was also associated with higher internalizing, externalizing, and total problems scores on the Child Behavior Checklist [29, 30] as well as the Socialization domain of the Vineland [42]. Individuals with more severe ADHD severity at age 18 years were also more likely to have co-occurring learning disorders [29].

Neuropsychological studies of children and adolescents with both TS and ADHD showed a similar increase in errors of omission and in the variability of their reaction times on the Conner’s Continuous Performance Task [43] compared to children with TS-only and unaffected controls [44]. On other neuropsychological tests including the Stroop Color-Word Interference Test [45], the Beery Visual-Motor Integration Test [46], and the Purdue Pegboard Test [47], the ADHD alone group showed significant deficits relative to the normal controls. The TS alone and the TS plus ADHD groups were intermediate in their performance but these differences were not significant. When ADHD is present in individuals with TS, the ADHD symptoms typically precede the onset of tic symptoms and are often associated with greater problems with self-esteem, peer acceptance, and academic achievement than the tics themselves [48]. Not surprisingly, comorbid ADHD symptoms in childhood have been associated with a decreased quality of life and global functioning in early adulthood for individuals with TS [5, 9, 4953]. Unfortunately, studies examining the long-term clinical course of ADHD, specifically in individuals with comorbid tics, are quite limited [28]. In the general ADHD population, however, it has been shown that the hyperactivity symptoms of ADHD generally improve during adolescence, whereas the inattention symptoms of ADHD often persist into adulthood [54].

Pharmacological treatment of ADHD in children with TS is recommended [9, 5456]. For example, a study conducted by the Tourette Syndrome Study Group demonstrated that both clonidine, an alpha-2 adrenergic agonist, and methylphenidate, a psychostimulant, are effective treatments for ADHD in individuals with comorbid tics [5557]. Case reports and clinical observations have suggested that stimulants may exacerbate tic symptoms in some individuals with TS [58]. For this reason, the pharmaceutical companies and FDA-approved package inserts currently list tic symptoms as a contraindication to the use of most psychostimulant medications. However, evidence from randomized clinical trials in children with comorbid tics suggests that methylphenidate typically does not cause an increase in tic severity [5557]. However, clinical experience and limited experimental evidence suggest that the use of amphetamine derivatives to treat ADHD may exacerbate tics, particularly when used at higher doses [59]. It is also of interest that alpha-2 agonists are most effective in treating tics when ADHD is present as a co-morbid condition [57].

Obsessive-compulsive disorder.

Roughly one-third to one-half of children with TS will experience comorbid OCD throughout their lifetime [9, 12]. Symptoms of OCD that are subclinical in severity are even more common. OCD symptoms in patients with TS often begin around the time that the tics reach their worst ever point, but symptoms can also appear de novo in later adolescence or adulthood. OCD patients with comorbid tics tend to have greater rates of symmetry obsessions, and counting, repeating, ordering, and arranging compulsions than pediatric-onset OCD patients without comorbid tic symptoms [6062]. Based on the results of a longitudinal follow-up study of 65 individuals with TS and 65 matched community controls without tic or OCD symptoms, higher levels of OCD severity in late adolescence are associated with a significantly lower level of global functioning [29]. OCD severity was also associated with higher internalizing, externalizing, and total problems scores on the Child Behavior Checklist [29, 30] as well as the Socialization domain of the Vineland [41]. Individuals with greater OCD severity at age18 years were also more likely to have co-occurring anxiety disorders and Conduct disorder [29].

Tic-related OCD has many distinctive features when compared to non-tic related OCD [60]. For example, children with OCD and comorbid tics are likely to have a worse response to selective-serotonin reuptake inhibitors (SSRIs) than children without comorbid tics [62]. In contrast, children with OCD, with or without comorbid tics, appear to have a similar response to cognitive behavioral therapy [62]. Another treatment option for OCD patients with comorbid tics is antipsychotic medication. A meta-analysis of antipsychotic augmentation trials for treatment refractory OCD suggests that OCD patients with comorbid tics on an SSRI may have an improved response to this intervention [63]. Long-term outcome studies of children with TS suggest that increased IQ and smaller caudate nucleus volumes on structural MRI scans obtained in childhood may be associated with increased OC symptoms in early adulthood [64]. Adulthood outcome studies suggest that childhood OCD patients with comorbid tics may have an increased likelihood of remission of OCD symptoms by adulthood [64]. These data suggest that OC symptoms in children with OCD and comorbid tics may follow a similar developmental trajectory to the tics themselves [65]. However, it is also important to note that among adults with persistent TS, comorbid OCD has been associated with higher levels of other comorbidity (ADHD, body dysmorphic disorder, trichotillomania, social phobia, substance use disorder) but not more severe tic symptoms [66].

Other comorbid conditions.

Children with TS have higher rates of comorbid developmental disorders including Autism Spectrum Disorders (ASD), learning disorders, disruptive behavior disorders, and major depression than the general population [8, 9, 24, 67]. In children with both ASD and TS it is not uncommon to observe motor stereotypies as well as motor and vocal tics. The symptoms of these comorbid conditions typically appear prior to the time that tics reach clinical attention. When present, aggressive treatment of these conditions is warranted. Higher rates of restless legs syndrome and migraines have also been reported although the etiological links across these disorders remains in doubt [6870]. Currently, there is no evidence to suggest that the recommended treatment of these conditions should differ between individuals with and without comorbid tic disorders. Explosive rage attacks can be particularly challenging in individuals with TS, but therapies such as parent management training and anger control training, which are effective in the general population, are also effective in TS [7173]. Children with TS experience comorbid depressive and anxiety disorders during the course of adolescence and early adulthood more frequently than unaffected controls [26, 29, 4853]. Roughly 60% of children with TS will experience one or more episodes of major depression and 40% will meet criteria for a non-OCD anxiety disorder [29]. Children with TS and their parents should be educated to recognize the signs and symptoms of these conditions. These conditions are even more sensitive to increases in psychosocial stress than is TS [21]. Finally, a variety of post infectious autoimmune conditions including Sydenham’s chorea [74], and pediatric neuropsychiatric disorders associated with streptococcal infections (PANDAS) [75], can present as new onset tic disorders. Although GABHS infections have been postulated as the main initial autoimmune response inciting event contributing to the sudden onset of tics and other neuropsychiatric symptoms in a subgroup of patients, it is well documented that sudden tic symptom onset or worsening can be triggered by other infectious agents (e.g., herpes simplex virus, varicella zoster virus, human immunodeficiency virus, Borrelia burgdorferi, Mycoplasma pneumoniae, sinusitis, and the common cold) [76]. This remains a controversial field, but the onset of tics in these cases is typically very sudden (overnight) and the tics are accompanied by the sudden onset of three or more other neuropsychiatric symptoms (including: a markedly increased level of anxiety, emotional lability, irritability, aggressive behavior, sudden difficulties with concentration or learning, developmental regression [loss of abilities], sleep difficulties, and urinary frequency and/or an increased urge to urinate) [77].

What parents need to know

Table 1 presents some of the key psychoeducational points that we typically convey to families when evaluating and treating children with TS [40]. In addition, educating peers and teachers about TS can also help a child become a ‘self-advocate’ and not feel ashamed of having a limited ability to control their tics. In our view, the sensory component of tics, the premonitory urges, is an essential ingredient in understanding TS. It is also a key element of Habit Reversal Training [18, 19]. Likewise, reviewing the natural history of TS (Fig. 1 & 2) and noting that the tics typically diminish considerably by the end of the second decade of life is another important point to emphasize. Indeed, more than three-quarters of children with significant childhood tic symptoms will experience fewer and/or less severe tics in early adulthood and over one-third will be completely tic free in adulthood. It is also worth noting that tics often disappear during the performance of familiar tasks that require focused attention and motor control such as playing a musical instrument, playing sports, or dancing. Such activities can be beneficial in general and can help children persevere through particularly challenging bouts of tics. Inquiring about and supporting a child’s strengths, interests, and independence is a key task of clinicians that will potentially ensure the best long term outcomes. Another key issue is that a greater proportion of children with TS experience developmental disorders, ADHD, learning disorders, and disruptive behavioral disorders than among the general population. Symptoms of these conditions generally precede the onset of tics. Given this high rate of co-occurrence, families need to know that the social, emotional, and academic outcomes in adulthood are not synonymous with tic outcomes. Although tics usually diminish by early adulthood, this is not always the case. As a result patients and families need to know that many adults with TS live happy, accomplished lives despite having persistent tic symptoms. It is also important to recognize that persistent severe tic symptoms, even after controlling for comorbid ADHD, are associated with lower levels of global functioning and higher levels of internalizing and externalizing problems [29]

Table 1:

Key Points

• Tourette syndrome (TS) is best understood as both a sensory as well as a motor
 disorder characterized by a reduction in the normal “automatic” ability to suppress or
 “gate” irrelevant information in sensory and motor domains. One common
 manifestation is the presence of ‘premonitory urges’ that commonly precede the
 onset of tics.
• Tics wax and wane in severity over weeks to months. It is important not to chase
 every increase in tic severity with medication and search for a psychological or medical
 explanation for each exacerbation.
• Psychosocial and physical illness can make tics temporarily worse as does fatigue
 and emotional excitement. A predictable environment with appropriate sleep and
 hygiene is often beneficial to individuals with TS.
• Tics often disappear during the performance of familiar tasks that require focused
 attention and motor control such as playing a musical instrument, playing sports, or
 dancing. Such activities can be beneficial in general and can help children persevere
 through particularly challenging bouts of tics.
• Educating parents, siblings, peers, and teachers about TS can help a child become
 a ‘self-advocate’ and not feel ashamed of being unable to control their tics. Inquiring
 about and supporting a child’s strengths, interests, and independence is a key task
 of clinicians as that will ensure the best long term outcomes.
• As children get older they typically develop a greater ability to suppress tics.
 Environments conducive to tic suppression result in reduced tic frequency without
 adverse consequences or a rebound in tic frequency or severity.
• The worst ever tic symptoms usually occur between 8 and 12 years.
• At present, cognitive behavioral interventions should be considered the first-line
 treatment for persons with tic disorders
• Pharmacological treatments for tics should focus on minimizing impairment, not
 eliminating tics. There is, as yet, no evidence that pharmacological treatments alter
 the long-term clinical course of TS.
• Although tics, in some form, persist in the majority of cases well into adulthood, by
 the end of the second decade of life more than half of the individuals with TS will
 have minimal or no tics. Unfortunately those individuals whose tic severity remains
 elevated typically have a diminished level of global functioning.
• Given the high rate of co-occurring conditions such as Attention Deficit Hyperactivity
 Disorder and Obsessive-Compulsive Disorder, the social, emotional, and academic
 outcomes in adulthood are not synonymous with tic outcomes. Inquiring about and
 providing appropriate interventions for these disorders and other comorbid
 conditions is another key to achieving the best long term outcomes.
• Many adults with TS live happy, accomplished lives despite having persistent tic
 symptoms. This is typically achieved by building on skills and interests throughout
 development and by not letting the tic symptoms interfere with the emergence of an
 independent life trajectory.

Unanswered questions, an agenda for future research

Although the phenomenology and natural history of TS and tic disorders is reasonably well established, more work needs to be done. In terms of measurement the Yale Global Tic Severity Scale (YGTSS) has emerged as the gold standard with excellent psychometric properties [14, 7880]. However, it has its limitations. Originally designed to apply to all individuals with any tic disorder, it is most widely used in clinical trials and in cross-sectional studies of children and adults with TS as opposed to population-based studies. As a result, the distribution of YGTSS scores in most of the clinical trials are skewed. This is most apparent in the ‘Number’ and ‘Frequency’ domains of the YGTSS [14]. Although the motor and vocal tics form separate factors [10,79], a single tic severity rating on the YGTSS may make more sense [81]. In addition, it is probable that monitoring the moment-to-moment patterns of intertic intervals may advance our understanding of the waxing and waning pattern of tics [20]. Other useful scales include the PUTS [17] and the TS Diagnostic Confidence Index [82]. It is likely that the intensity of premonitory urges as measured by the subjective ratings on the PUTS may be positively associated with the levels of activation in the insula, anterior cingulate, supplementary motor area, and the primary somatosensory cortex. Activations in these areas are known to precede and accompany tic onset [83, 84]

Other enduring questions concern ‘why.’ Why do tics emerge when they do? Why do motor tics typically precede vocal tics? Why is there a rostral→caudal progression of tic symptoms? Why are the vast majority of tic disorders transient or limited to a chronic motor tic disorder [57]? Why does psychosocial stress, emotional excitement, and fatigue impact tic severity [2124]? Why do tics remit, or at least improve dramatically, in most individuals by the end of the second decade of life [13, 15 26]? Why do ADHD and tic-related OCD occur as commonly as they do [4, 11, 12, 29]? Why are these disorders so much more common in individuals with TS versus a chronic motor tic disorder [7]? What about restless legs syndrome and migraines [6971]? Here genetic [36, 8487], neuropathological [33, 34, 8891], neurophysiological [92], and neuroimaging studies [35, 83, 84, 92] combined with emerging animal models [9398] and the study of TS patient-specific induced pluripotent stem cells [99] may finally yield definitive answers.

Acknowledgments

The authors acknowledge the National Institute of Mental Health support of the Yale Child Study Center Research Training Program (JFL, MHB), K05MH076273 (JFL); K23MH091240 (MHB), the National Institute of Health Loan Repayment Program (MHB); the support of the Tourette Syndrome Association, Inc. (JFL); and the APIRE/Eli Lilly Psychiatric Research Fellowship (MHB). We also acknowledge that portions of this review were modeled on two previous reviews: Leckman JF, Bloch MH, Scahill L, King RA. Tourette syndrome: the self under siege. J Child Neurol. 2006;21(8):642–9 and Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res. 2009;67(6):497–501 [9]

Footnotes

Full Financial Disclosures of all Authors for the Past Year: Disclosure: Dr. Leckman has received research support from the National Institutes of Health and the Tourette Syndrome Association. He has received salary support from the National Institutes of Health. He has received support from the Klingenstein Third Generation Foundation from the medical student fellowship program. He has received royalties from John Wiley & Sons, McGraw Hill, and Oxford University Press. Dr. Bloch has received research support from the National Institutes of Health and the Tourette Syndrome Association and the American Psychiatric Institute for Research and Education/Eli Lilly Psychiatric Research Fellowship program. He has also received salary support from the National Institutes of Health. Drs. King reports no biomedical financial interests or potential conflicts of interest.

Contributor Information

James F. Leckman, Yale Child Study Center, Yale University School of Medicine, New Haven, CT, USA

Robert A. King, Yale Child Study Center, Yale University School of Medicine, New Haven, CT, USA

Michael H. Bloch, Yale Child Study Center, Yale University School of Medicine, New Haven, CT, USA

References

  • [1].Hollenbeck PJ: Insight and hindsight into Tourette syndrome. Adv Neurol 2001;85:363–367. [PubMed] [Google Scholar]
  • [2].Kushner H A Cursing Brain: The Histories of Tourette Syndrome Cambridge, MA: Harvard University Press, 2000. [Google Scholar]
  • [3].Walkup JT, Ferrão Y, Leckman JF, et al. Tic disorders: some key issues for DSM-5. Depress Anxiety 2010;27(6):600–10. [DOI] [PubMed] [Google Scholar]
  • [4].Scahill L, Sukhodolsky DG, Williams SK, Leckman JF. Public health significance of tic disorders in children and adolescents. Adv Neurol 2005;96:240–8. [PubMed] [Google Scholar]
  • [5].Robertson MM, Eapen V, Cavanna AE. The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective. J Psychosom Res 2009;67(6):475–83. [DOI] [PubMed] [Google Scholar]
  • [6].Khalifa N, von Knorring AL. Prevalence of tic disorders and Tourette syndrome in a Swedish school population. Dev Med Child Neurol 2003;45:315–9. [DOI] [PubMed] [Google Scholar]
  • [7].Khalifa N, von Knorring AL. Psychopathology in a Swedish population of school children with tic disorders. J Am Acad Child Adolesc Psychiatry 2006;45:1346–53. [DOI] [PubMed] [Google Scholar]
  • [8].Scahill L, Dalsgaard S, Bradbury K. The Prevalence of Tourette Syndrome and its Relationship to Clinical Features. In: Martino D, Leckman JF, editors. Tourette Syndrome Oxford: Oxford University Press, 2013. pp. 121–133. [Google Scholar]
  • [9].Leckman JF. Tourette’s syndrome. Lancet 2002;360:1577–86. [DOI] [PubMed] [Google Scholar]
  • [10].Leckman JF, Bloch MH, Sukhodolsky DG, Scahill L, King RA. Phenomenology of Tics and Sensory Urges: The Self Under Siege. In: Martino D, Leckman JF, editors. Tourette Syndrome Oxford: Oxford University Press, 2013. pp. 3–25. [Google Scholar]
  • [11].Rothenberger A, Roessner V. The Phenomenology of Attention Deficit Hyperactivity Disorder in Tourette Syndrome. In: Martino D, Leckman JF, editors. Tourette Syndrome Oxford: Oxford University Press, 2013. pp. 26–49. [Google Scholar]
  • [12].Ferrão YA, de Alvarenga PG, Hounie AG, de Mathis MA, de Rosário MC, Miguel E. The Phenomenology of Obsessive-Compulsive Symptoms in Tourette Syndrome. In: Martino D, Leckman JF, editors. Tourette Syndrome Oxford: Oxford University Press, 2013. pp. 50–74. [Google Scholar]
  • [13].Bloch MH. Clinical Course and Adulthood Outcome in Tourette Syndrome. In: Martino D, Leckman JF, editors. Tourette Syndrome Oxford: Oxford University Press, 2013. pp. 107–120. [Google Scholar]
  • [14].Leckman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989;28(4):566–73. [DOI] [PubMed] [Google Scholar]
  • [15].Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 1998;102(1 Pt 1): 14–9. [DOI] [PubMed] [Google Scholar]
  • [16].Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette’s syndrome. Am J Psychiatry 1993;150:98–102. [DOI] [PubMed] [Google Scholar]
  • [17].Woods DW, Piacentini J, Himle MB, Chang S. Premonitory Urge for Tics Scale (PUTS): initial psychometric results and examination of the premonitory urge phenomenon in youths with Tic disorders. J Dev Behav Pediatr 2005;26:397–403. [DOI] [PubMed] [Google Scholar]
  • [18].Piacentini J, Woods DW, Scahill L, et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA 2010;303(19):1929–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Wilhelm S, Peterson AL, Piacentini J, Woods DW, Deckersbach T, Sukhodolsky DG, Chang S, Liu H, Dziura J, Walkup JT, Scahill L. Randomized trial of behavior therapy for adults with Tourette syndrome. Arch Gen Psychiatry 2012;69(8):795–803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [20].Peterson BS, Leckman JF. The temporal dynamics of tics in Gilles de la Tourette syndrome. Biol Psychiatry 1998; 44:1337–48. [DOI] [PubMed] [Google Scholar]
  • [21].Lin H, Katsovich L, Ghebremichael M, et al. Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. J Child Psychol Psychiatry 2007;48(2):157–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Conelea CA, Woods DW. The influence of contextual factors on tic expression in Tourette’s syndrome: a review. J Psychosom Res 2008; 65:487–96. [DOI] [PubMed] [Google Scholar]
  • [23].Buse J, Kirschbaum C, Leckman JF, Munchau A, Veit Roessner V. The modulating role of stress in the development and course of Tourette’s syndrome, Behavior Modification, In press. [DOI] [PubMed]
  • [24].Steinberg T, Harush A, Barnea M, Dar R, Piacentini J, Woods D, Shmuel-Baruch S, Apter A. Tic-related cognition, sensory phenomena, and anxiety in children and adolescents with Tourette syndrome. Compr Psychiatry 2013; 54(5):462–6. [DOI] [PubMed] [Google Scholar]
  • [25].Specht MW, Woods DW, Nicotra CM, Kelly LM, Ricketts EJ, Conelea CA, Grados MA, Ostrander RS, Walkup JT. Effects of tic suppression: ability to suppress, rebound, negative reinforcement, and habituation to the premonitory urge. Behav Res Ther 2013;51(1):24–30. [DOI] [PubMed] [Google Scholar]
  • [26].Bloch MH, Peterson BS, Scahill L, et al. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med 2006;160:65–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Gilles de la Tourette G. Étude sur une affection nerveuse caractérisée par de I’incoordination motrice accompagnée d’écholalie et de copralalie. Archive Neurologie 1885;9:19–42, 158–200. [Google Scholar]
  • [28].Spencer T, Biederman M, Coffey B, et al. The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:842–7. [DOI] [PubMed] [Google Scholar]
  • [29].Gorman DA, Thompson N, Plessen KJ, et al. Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study. Br J Psychiatry 2010;197(1):36–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Achenbach TM. Manual for the Child Behaviour Checklist/4–18 and 1991 Profile University of Vermont Press, 1991. [Google Scholar]
  • [31].Bloch MH, Sukhodolsky DG, Leckman JF, Schultz RT. Fine-motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette’s syndrome. J Child Psychol Psychiatry 2006;47:551–9. [DOI] [PubMed] [Google Scholar]
  • [32].Bloch MH, Leckman JF, Zhu H, Peterson BS. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005;65:1253–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Kalanithi PS, Zheng W, Kataoka Y, et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 2005;102:13307–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [34].Kataoka Y, Kalanithi PS, Grantz H, et al. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J Comp Neurol 2010;518(3):277–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [35].Leckman JF, Vaccarino FM, Kalanithi PS, Rothenberger A. Tourette syndrome: a relentless drumbeat—driven by misguided brain oscillations. J Child Psychol Psychiatry 2006;47:537–50. [DOI] [PubMed] [Google Scholar]
  • [36].Fernandez TV, State MW. Genetic Susceptibility in Tourette Syndrome. In: Martino D, Leckman JF, editors. Tourette Syndrome Oxford: Oxford University Press, 2013. pp. 137–155. [Google Scholar]
  • [37].Singer HS. The Neurochemistry of Tourette Syndrome. In: Martino D, Leckman JF, editors. Tourette Syndrome Oxford: Oxford University Press, 2013. pp. 276–300. [Google Scholar]
  • [38].Greene DJ, Black KJ, Schlaggar BL. Neurobiology and Functional Anatomy of Tic Disorders. In: Martino D, Leckman JF, editors. Tourette Syndrome Oxford: Oxford University Press, 2013. pp. 238–275. [Google Scholar]
  • [39].Woods DW, Piacentini J, Chang S, Deckersbach T, Ginsburg G, Peterson A, Scahill LD, Walkup JT, Wilhelm S: Managing Tourette Syndrome: A Behavioral Intervention for Children and Adults Therapist Guide. Treatments that Work series New York: Oxford University Press, 2008. [Google Scholar]
  • [40].Lebowitz ER, Scahill L. Psychoeducational Interventions: What Every Parent and Family Member Needs to Know. In: Martino D, Leckman JF, editors. Tourette Syndrome Oxford: Oxford University Press, 2013. pp. 487–502. [Google Scholar]
  • [41].Roessner V, Rothenberger A. Pharmacological treatment of Tics In: Martino D, Leckman JF, editors. Tourette Syndrome Oxford: Oxford University Press, 2013. pp. 524–552. [Google Scholar]
  • [42].Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptive Behaviour Scales. American Guidance Service, 1984. [Google Scholar]
  • [43].Conners CK.Conners’ Continuous Performance Test North Tonawanda, NY: Multi-Health Systems; 1995. [Google Scholar]
  • [44].Sukhodolsky DG, Landeros-Weisenberger A, Scahill L, et al. Neuropsychological functioning in children with Tourette syndrome with and without attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010; 49(11):1155–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [45].Golden CJ. Stroop Color and Word Test: A Manual for Clinical and Experimental Uses Wood Dale, IL: Stoelting; 1978. [Google Scholar]
  • [46].Beery KE. The Beery–Buktenica Developmental Test of Visual–Motor Integration (4th ed.). Parsippany, NJ: Modern Curriculum Press; 1997. [Google Scholar]
  • [47].Tiffen J Purdue Pegboard Test Chicago, IL: Scientific Research Associates; 1968. [Google Scholar]
  • [48].Sukhodolsky DG, Scahill L, Zhang H, et al. Disruptive behavior in children with Tourette’s syndrome: association with ADHD comorbidity, tic severity, and functional impairment. J Am Acad Child Adolesc Psychiatry 2003;42:98–105. [DOI] [PubMed] [Google Scholar]
  • [49].Hoekstra PJ, Steenhuis MP, Troost PW, et al. Relative contribution of attention-deficit hyperactivity disorder, obsessive-compulsive disorder, and tic severity to social and behavioral problems in tic disorders. J Dev Behav Pediatr 2004;25: 272–9. [DOI] [PubMed] [Google Scholar]
  • [50].Lebowitz ER, Motlagh MG, Katsovich L, King RA, Lombroso PJ, Grantz H, Lin H, Bentley MJ, Gilbert DL, Singer HS, Coffey BJ, Kurlan RM, Leckman JF. Tourette syndrome in youth with and without obsessive compulsive disorder and attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry 2012;21(8):451–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [51].Bernard BA, Stebbins GT, Siegel S, et al. Determinants of quality of life in children with Gilles de la Tourette syndrome. Mov Disord 2009;24:1070–3. [DOI] [PubMed] [Google Scholar]
  • [52].Müller-Vahl K, Dodel I, Müller N, et al. Health-related quality of life in patients with Gilles de la Tourette’s syndrome. Mov Disord 2010;25(3):309–14. [DOI] [PubMed] [Google Scholar]
  • [53].Eddy CM, Rizzo R, Gulisano M, Agodi A, Barchitta M, Calì P, Robertson MM, Cavanna AE. Quality of life in young people with Tourette syndrome: a controlled study. J Neurol. Quality of life in young people with Tourette syndrome: a controlled study. J Neurol 2011;258(2):291–301. [DOI] [PubMed] [Google Scholar]
  • [54].Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006; 36:159–65. [DOI] [PubMed] [Google Scholar]
  • [55].Tourette’s Syndrome Study Group. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002; 58:527–36. [DOI] [PubMed] [Google Scholar]
  • [56].Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit hyperactivity disorder in children with comorbid tic disorders. JAACAP 2009;48:884–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [57].Weisman H, Qureshi IA, Leckman JF, Scahill L, Bloch MH. Systematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neurosci Biobehav Rev 2013;37(6):1162–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [58].Lowe TL, Cohen DJ, Detlor J, et al. Stimulant medications precipitate Tourette’s syndrome. JAMA 1982; 247:1168–9. [PubMed] [Google Scholar]
  • [59].Denys D, de Vries F, Cath D, et al. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder. Eur Neuropsychopharmacol 2013; 23(11):1423–31. [DOI] [PubMed] [Google Scholar]
  • [60].Leckman JF, Grice DE, Barr LC, et al. Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety 1994;1:208–15. [PubMed] [Google Scholar]
  • [61].Hanna GL, Piacentini J, Cantwell DP, Fischer DJ, Himle JA, Van Etten M. Obsessive-compulsive disorder with and without tics in a clinical sample of children and adolescents. Depress Anxiety 2002;16(2):59–63. [DOI] [PubMed] [Google Scholar]
  • [62].Leckman JF, Denys D, Simpson HB, et al. Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-5. Depress Anxiety 2010;27(6):507–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [63].March JS, Franklin ME, Leonard H, et al. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 2007;61:344–7. [DOI] [PubMed] [Google Scholar]
  • [64].Bloch MH, Landeros-Weisenberger A, Kelmendi B, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006;11:622–32. [DOI] [PubMed] [Google Scholar]
  • [65].Bloch MH, Craiglow BG, Landeros-Weisenberger A, et al. Predictors of early adult outcome in pediatric-onset obsessive-compulsive disorder. Pediatrics, 2009; 124(4):1085–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [66].Lewin AB, Chang S, McCracken J, McQueen M, Piacentini J. Comparison of clinical features among youth with tic disorders, obsessive-compulsive disorder (OCD), and both conditions. Psychiatry Res 2010;178(2):317–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [67].Coffey BJ, Miguel EC, Biederman J, Baer L, Rauch SL, O’Sullivan RL, Savage CR, Phillips K, Borgman A, Green-Leibovitz MI, Moore E, Park KS, Jenike MA. Tourette’s disorder with and without obsessive-compulsive disorder in adults: are they different? J Nerv Ment Dis 1998;186(4):201–6. [DOI] [PubMed] [Google Scholar]
  • [68].Kurlan R, Whitmore D, Irvine C, et al. Tourette’s syndrome in a special education population: a pilot study involving a single school district. Neurology 1994;44:699–702. [DOI] [PubMed] [Google Scholar]
  • [69].Lespérance P, Djerroud N, Diaz Anzaldua A, et al. Restless legs in Tourette syndrome. Mov Disord 2004;19(9):1084–7. [DOI] [PubMed] [Google Scholar]
  • [70].Kwak C, Vuong KD, Jankovic J. Migraine headache in patients with Tourette syndrome. Arch Neurol 2003; 60(11):1595–8. [DOI] [PubMed] [Google Scholar]
  • [71].Silberstein SD. Association between restless legs syndrome and migraine. J Neurol Neurosurg Psychiatry 2010;81(5):473–5. [DOI] [PubMed] [Google Scholar]
  • [72].Budman CL, Rockmore L, Stokes J, Sossin M. Clinical phenomenology of episodic rage in children with Tourette syndrome. J Psychosom Res 2003;55:59–65. [DOI] [PubMed] [Google Scholar]
  • [73].Scahill L, Sukhodolsky DG, Bearss K, Findley D, et al. Randomized trial of parent management training in children with tic disorders and disruptive behavior. J Child Neurol 2006;21:650–6. [DOI] [PubMed] [Google Scholar]
  • [74].Sukhodolsky DG, Vitulano LA, Carroll DH, et al. Randomized trial of anger control training for adolescents with Tourette’s syndrome and disruptive behavior. J Am Acad Child Adolesc Psychiatry 2009;48(4):413–21. [DOI] [PubMed] [Google Scholar]
  • [75].Mercadante MT, Campos MC, Marques-Dias MJ, et al. . Vocal tics in Sydenham’s chorea. J Am Acad Child Adolesc Psychiatry 1997;36(3):305–6. [DOI] [PubMed] [Google Scholar]
  • [76].Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998;155(2):264–71. [DOI] [PubMed] [Google Scholar]
  • [77].Murphy TK, Kurlan R, Leckman J. The immunobiology of Tourette’s disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol 2010;20(4):317–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [78].Swedo SE, Leckman JF, Rose NR. From Research Subgroup to Clinical Syndrome: Modifying the PANDAS Criteria to Describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Pediatr Therapeut 2012; 2:113 10.4172/2161-0665.1000113 [DOI] [Google Scholar]
  • [79].Storch EA, Murphy TK, Geffken GR, et al. Reliability and validity of the Yale Global Tic Severity Scale. Psychol Assess 2005;17(4):486–91. [DOI] [PubMed] [Google Scholar]
  • [80].Storch EA, Murphy TK, Fernandez M, et al. Factor-analytic study of the Yale Global Tic Severity Scale. Psychiatry Res 2007;149(1–3):231–7. [DOI] [PubMed] [Google Scholar]
  • [81].Jeon S, Walkup JT, Woods DW, Peterson A, Piacentini J, Wilhelm S, Katsovich L, McGuire JF, Dziura J, Scahill L. Detecting a clinically meaningful change in tic severity in Tourette syndrome: A comparison of three methods. Contemp Clin Trials 2013; 36(2):414–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [82].Robertson MM, Banerjee S, Kurlan R, et al. The Tourette syndrome diagnostic confidence index: development and clinical associations. Neurology 1999;53(9):2108–12. [DOI] [PubMed] [Google Scholar]
  • [83].Bohlhalter S, Goldfine A, Matteson S, et al. Neural correlates of tic generation in Tourette syndrome: An event-related functional MRI study. Brain 2006; 129:2029–37. [DOI] [PubMed] [Google Scholar]
  • [84].Hampson M, Tokoglu F, King RA, et al. Brain areas coactivating with motor cortex during chronic motor tics and intentional movements. Biol Psychiatry 2009; 65:594–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [85].Abelson JF, Kwan KY, O’Roak BJ, et al. Sequence variants in SLITRK1 are associated with Tourette’s syndrome. Science 2005;310(5746):317–20. [DOI] [PubMed] [Google Scholar]
  • [86].Stillman AA, Krsnik Z, Sun J, et al. Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome. J Comp Neurol 2009;513(1):21–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [87].Ercan-Sencicek AG, Stillman AA, Ghosh AK, et al. L-histidine decarboxylase and Tourette’s syndrome. N Engl J Med 2010;362(20):1901–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [88].Hong JJ, Loiselle CR, Yoon DY, et al. Microarray analysis in Tourette syndrome postmortem putamen. J Neurol Sci 2004; 225(1–2):57–64. [DOI] [PubMed] [Google Scholar]
  • [89].Yoon DY, Gause CD, Leckman JF, Singer HS. Frontal dopaminergic abnormality in Tourette syndrome: a postmortem analysis. J Neurol Sci 2007;255(1–2):50–6. [DOI] [PubMed] [Google Scholar]
  • [90].Morer A, Chae W, Henegariu O, et al. Elevated expression of MCP-1, IL-2 and PTPR-N in basal ganglia of Tourette syndrome cases. Brain Behav Immun 2010;24(7):1069–73. [DOI] [PubMed] [Google Scholar]
  • [91].Lennington JB, Coppola G, Kataoka-Sasaki Y, et al. Transcriptome analysis of the human striatum in Tourette syndrome. Biol Psychiatry, in press. [DOI] [PMC free article] [PubMed]
  • [92].Zebardast N, Crowley MJ, Bloch MH, Mayes LC, Wyk BV, Leckman JF, Pelphrey KA, Swain JE. Brain mechanisms for prepulse inhibition in adults with Tourette syndrome: initial findings. Psychiatry Res 2013;214(1):33–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [93].McCairn KW, Imamura Y, Isoda M. Animal Models of Tics. In: Martino D, Leckman JF, editors. Tourette Syndrome Oxford: Oxford University Press, 2013. pp. 329–358. [Google Scholar]
  • [94].Hamann M, Richter A, Meillasson FV, et al. Age-related changes in parvalbumin-positive interneurons in the striatum, but not in the sensorimotor cortex in dystonic brains of the dt(sz) mutant hamster. Brain Res 2007;1150:190–9. [DOI] [PubMed] [Google Scholar]
  • [95].Hamann M, Sohr R, Morgenstern R, Richter A. Extracellular amino acid levels in the striatum of the dt(sz) mutant, a model of paroxysmal dystonia. Neuroscience 2008;157(1):188–95. [DOI] [PubMed] [Google Scholar]
  • [96].Katayama K, Yamada K, Ornthanalai VG, et al. Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities. Mol Psychiatry 2010;15(2):177–84. [DOI] [PubMed] [Google Scholar]
  • [97].Castellan Baldan L, Williams KA, Gallezot JD, …State MW, Pittenger C. Histidine Decarboxylase Deficiency causes Tourette syndrome: Parallel findings in humans and mice. Neuron 2014; 81: 77–90 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [98].Chen SK, Tvrdik P, Peden E, et al. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 2010; 141(5):775–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [99].Vaccarino FM, Urban AE, Stevens H, et al. The promise of stem cell research for neuropsychiatric disorders. J Child Psychol Psychiatry 2011; 52(4):504–16. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES